AIM HIGHer CLINICAL STUDY

Explore a clinical study for people living with heart failure

The AIM HIGHer study is a FDA approved clinical research study designed to evaluate the safety and effectiveness of a therapy called Cardiac Contractility Modulation (CCM®) in people who have heart failure and ongoing symptoms despite medical treatment. This therapy is being studied to better understand how it may help certain people with heart failure.

What is heart failure?

Heart failure occurs when the heart muscle can’t pump blood as well as it should. This can lead to a buildup of fluid in the body and reduced oxygen supply to your organs and tissues.

Shortness of breath during activity or at rest

Fatigue or low energy

Swelling in legs or abdomen

Weight gain from fluid retention

Dizziness or difficulty concentrating

These symptoms may persist even when you are on medications.

What is CCM® therapy?

Eligible enrolled participants receive an implanted device delivering electrical signals to the heart muscle during each heartbeat.

Implanted under the skin in either the right or left pectoral area

Uses two small wires connected to the heart

Rechargeable and designed for long-term use

The study explains the procedures, risks and alternatives before a decision to participate.

CCM Therapy

Could you be eligible?

The study may be a good fit for you if you meet the following basic criteria:

18 years or older

Diagnosed with heart failure

Ongoing symptoms despite treatment

Ejection fraction between 40% and 70%, assessed by cardiologist via echocardiogram

Further eligibility is determined through medical testing and review after consent.

Why consider participating?

Limited treatment options for this type of heart failure

Continue standard medical care from your doctor

May help researchers better understand future treatment options

Closely monitored by specialized heart teams

Participation is voluntary and you may leave at any time

Early access to new heart failure technology and therapies

Clinical study participants may not all experience benefit and may experience risk-related complications.

What can I expect in the study?

1

Screening tests

Confirm eligibility and complete baseline tests.

2

Implantation

Implantation of a small device similar in size to a pacemaker.

3

Follow-up visits

Scheduled follow-up visits with study team and doctors.

4

Questionnaires

Questionnaires about health and symptoms.

The first phase lasts 18 months, with follow-up monitoring up to 5 years.

Frequently Asked Questions

Where is the study being conducted?

Up to 150 hospital centers across the USA, aiming to enroll up to 1,500 patients.

Will I need to pay for this?

The procedure and related costs may be covered by insurance; there may be out-of-pocket copays and Impulse Dynamics may cover a portion.

How can I get more info?

Complete a brief survey and, if qualified, connect with an Impulse Dynamics representative.

Take the next step

Find out if you may be eligible for the AIM-HIGHer clinical study.